When PD-L1 on tumor cells binds to PD-1 on T cells, this interaction suppresses T cell proliferation, cytokine secretion (e.g., IFN-γ, TNF-α), and cytotoxic activity, ultimately leading to T cell dysfunction or exhaustion (19, 20). The gene discussed is IFNG; the disease is neoplasm.